Archived Post
..Entre los tres grandes, destaca el fuerte crecimiento del laboratorio suizo Novartis, con un alza del 9% hasta los 22.059 millones y que ya le pisa los talones a Pfizer. A pesar de que su principal blockbuster, el antitumoral Glivec, cede terreno..
Note: This is an archived weblink and the information may be outdated or no longer relevant.
Check the box if you have read and agree to our Terms & Privacy.
We may use cookies to give you the best experience. If you do nothing we'll assume that it's ok.
The information forward from this site may be provided by third parties. We will not be responsible with outside links, contents from source of information, methods of using, using or consequence of contents with users. All direct or indirect risk related to use of this site is borne entirely by you, the user.
We use advertising companies as Google AdSense, to serve ads when you visit our website. These companies may use information (not including your name, address, email address, or telephone number) about your visits to this and other websites in order to provide advertisements about goods and services of interest to you. If you would like more information about this practice and to know your choices about not having this information used by these companies, see https://policies.google.com/technologies/ads.